The field of breast imaging is constantly evolving and has seen rapid advances in technology over the last 2 decades. Controversies surrounding breast cancer screening have also been gaining ground, despite unequivocal benefits and a decline in mortality of nearly 30%. There is talk of a paradigm shift in thinking from “population-based” screening to “personalized risk based” screening.